Cita APA

Nakaya, S., Ogawa, R., Hayakawa, S., Fujihata, S., Okubo, T., Sagawa, H., . . . Takiguchi, S. (2021). Serum IgG level is a predicting factor for the response to neoadjuvant chemotherapy in patients with esophageal squamous cell carcinoma. World J Surg Oncol.

Chicago Style Citation

Nakaya, Seiichi, et al. "Serum IgG Level Is a Predicting Factor for the Response to Neoadjuvant Chemotherapy in Patients With Esophageal Squamous Cell Carcinoma." World J Surg Oncol 2021.

Cita MLA

Nakaya, Seiichi, et al. "Serum IgG Level Is a Predicting Factor for the Response to Neoadjuvant Chemotherapy in Patients With Esophageal Squamous Cell Carcinoma." World J Surg Oncol 2021.